Craniomaxillofacial (CMF) Devices And Equipment Global Market Report 2023 – By Product (Cranial Flap Fixation, CMF Distraction, Temporomandibular Joint Replacement, Thoracic Fixation, Bone Graft Substitute, MF Plate and Screw Fixation), By Material (Metals and alloys, Polymers), By End User (Hospital, Ambulatory Surgical Center), By Application (Neurosurgery & ENT, Orthognathic and Dental Surgery, Plastic Surgery) – Market Size, Trends, And Global Forecast 2023-2032

Orthopedic prosthetics are artificial devices that replace a missing body part that may be lost through trauma, disease, surgical removal of body appendage, disabling illness, or congenital conditions. The main product types of orthopedic prosthetics are upper extremity prosthetics, lower extremity prosthetics, sockets, and other products. Orthopedic prosthetics are artificial devices used to replace a missing body part lost due to disease, trauma, and surgical removal of body appendage, disabling illness, or congenital conditions. The technologies involved are conventional orthopedic prosthetics, electric-powered orthopedic prosthetics, and hybrid orthopedic prosthetics. The end-users are hospitals, prosthetic clinics, rehabilitation centres, and others. The global orthopedic prosthetics market is segmented - 1) By Product Type: Upper Extremity Prosthetics, Lower Extremity Prosthetics, Sockets, Other Products 2) By End Users: Hospitals, Prosthetic Clinics, Rehabilitation Center, Other End Users 3) By Technology: Conventional orthopedic prosthetics, Electric-powered orthopedic prosthetics, Hybrid orthopedic prosthetics The global orthopedic prosthetics market size will grow from $1.86 billion in 2022 to $1.96 billion in 2023 at a compound annual growth rate (CAGR) of 5.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic prosthetics is expected to grow to $2.42 billion in 2027 at a CAGR of 5.4%. The orthopedic prosthetics market is being driven by an increasing number of trauma cases and accidental injuries. The trauma cases and accidental injuries are caused by various factors such as road accidents, sports injuries, other medical complications, and work-related accidents. Most of these injuries may require amputations and prosthetic devices to replace the lost body part. For instance, 2.1 million people are living with limb loss in the USA, and that number is expected to double by 2050. 185,000 people in the U.S have an amputation each year. This means that 300 to 500 amputations have been performed every day. Therefore, driving the demand for orthopedic prosthetics, thus growth in the orthopedic prosthetics market. Major players in the orthopedic prosthetics market are Otto Bock HealthCare GmbH, Blatchford Ltd., Zimmer Biomet Inc., DePuy Synthes, Stryker Corporation, The Ohio Willow Wood Co., Ossur, Smith and Nephew PLC., Biomet Inc., and Touch Bionics Inc. The orthopedic prosthetics market is being restrained by entry barriers due to guidelines by the FDA's regulatory control over these devices based on the risks associated with them. These devices fall into the class III category as per the FDA, which includes devices involving high risk associated with the usage. Class III devices are required to undergo a premarket approval application (PMA), which is the FDA process of scientific evaluation for assessing the safety of these devices. Such stringent guidelines associated with these devices are creating an entry barrier and thus restraining the orthopedic prosthetics market. For instance, DePuy's hip prosthetic device was denied approval by the FDA after it was assessed as unsafe, thus creating an entry barrier and restraining the market. The companies in the orthopedic prosthetics market are witnessing the emergence of 3D printed orthopedic prosthetics. 3D printing is a process that involves a digital model being transformed into a three-dimensional solid object. 3D printed orthopedic prosthetics are devices that are manufactured by the process of 3D printing. These devices have shorter lead times, lower costs and consistent quality. For instance, Zdravprint is a Russian company that is developing prosthetics for the hand, elbow, and shoulder using 3D printing technology. The orthopedic prosthetics market is regulated as per the guidelines by the food and drug administration (FDA). The FDA has subjected these devices under the class III category, which includes those devices involving a high risk associated with the usage. Class III devices are required to undergo a premarket approval application (PMA) before they can be used. PMA is the process followed by the FDA for scientific evaluation, to assess the safety of the devices. If a PMA application is found to be lacking valid clinical assessment and correct scientific reasoning, it impacts the FDA's approval and prevents the prosthetic device from being released into the market. In October 2022, Patient Square Capital, a US-based healthcare investment firm acquired Hanger Inc for $18.75 in cash per stock. The acquisition would make Hanger a private company and help it better serve its customers and continue its growth. Hanger inc is a US-based manufacturer of Orthotic and prosthetic patient care services and solutions. North America was the largest region in the global orthopedic prosthetics market in 2022. Western Europe was the second-largest region in the orthopedic prosthetics market report. The regions covered in the orthopedic prosthetics industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the orthopedic prosthetics market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The orthopedic prosthetics market consists of sales of upper extremity prosthetics, lower extremity prosthetics, sockets, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic prosthetics market research report is one of a series of new reports from The Business Research Company that provides orthopedic prosthetics market statistics, including orthopedic prosthetics industry global market size, regional shares, competitors with a orthopedic prosthetics market share, detailed orthopedic prosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic prosthetics industry. This orthopedic prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Orthopedic accessories refer to the products that are used to fix or remove implants from the body. The main types of orthopedic accessories are bone cement, casting system, and removal system. Bone cement is the biomaterial obtained by mixing a powder phase and a liquid phase, which is molded and implanted as a paste and can be set once implanted in the body. The various application is hip, knee, and spine. The various end-users include hospitals, orthopedic clinics, and trauma fixation centres. The global orthopedic accessories market is segmented - 1) By Type: Bone Cement, Casting System, Removal System 2) By Application: Hip, Knee, Spine 3) By End User: Hospital, Orthopedic Clinic, Trauma Fixation Center The global orthopedic accessories market size will grow from $3.25 billion in 2022 to $3.36 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic accessories is expected to grow to $3.82 billion in 2027 at a CAGR of 3.2%. The increase in the number of medical cases due to road and sports accidents is driving the orthopedic accessories market. The probability of bones and other muscle tissues getting ruptured is high in the road and sports accidents, thus requiring orthopedic accessories like arm support, knee braces, and hip support for providing rigid support to the ruptured tissue and broken joint/bones during the treatment. Orthopedic accessories immobilize the bones and give them time to heal. Also, orthopedic accessories like bone cement and casting help in joining broken bones and filling in the void present in or between the bones. According to a report published by WHO, around 20-50 million people globally receive non-fatal injuries every year due to road accidents. Similarly, according to a survey by Stanford Children's Health, more than 3.5 million children aged 14 or younger get hurt every year by playing sports or by participating in some recreational activity. As the number of road and sports accidents increases, the number of medical cases requiring orthopedic accessories to get proper treatment will increase, thus driving the orthopedic accessories market. Major players in the orthopedic accessories market are Stryker Corporation, Zimmer-Biomet Holding, DePuy Synthes, Smith and Nephew PLC., McDavid, Aesculap Implant System, Conmed Corporation, Donjoy, NuVasive, and Medtronic PLC. The high rate of product recalls is restraining the orthopedic accessories market. Product Recall is a process of retrieving all defective products that have been sold or are available in the market. If an orthopedic Accessories company recalls a product from the market, the company takes up all the cost of fixing the defective product and the cost of replacement. This cost of replacement for large companies can go up to multi-billion dollars, hence restraining the growth of the company and for the whole market as well. For example, in the year 2022, DePuy Orthopedics recalled its Modular Cathcart Fracture Head Hip Ball due to issues in its how to use guide. According to a study by researchers of the University of Texas Medical and Naval Medical Center, Orthopedic devices represented 12% of all medical device recalls. This high recall rate is affecting the sales of orthopedic accessories and resulting in additional costs for manufacturing companies, in terms of repair and replacement of those devices, thus hampering the growth of the market. Companies in the orthopedic accessories market are increasingly using 3D printing technology to improve production efficiency and for making customized accessories as per the patient's requirements. 3D Printing technology is a process of making complex structures that are built by stacking up thin layers of a material and cutting out unwanted parts. In the case of orthopedic treatment, many people have different body shapes and sizes. 3D Printing allows companies to manufacture accessories as per the requirement of the patient. For example, the ZSFab company used 3D Printing technology to manufacture orthopedic accessories like neck braces and wrist casts. Also, companies like Stryker, Medtronic, and Smith & Nephew are working on 3D printing to improve manufacturing efficiencies and product quality. The orthopedic accessories market is regulated by authorities such as the US FDA and the Europen Council. For instance, EU Medical Devices Regulation (MDR 2017/745) is set to replace 2 existing directives, and this new regulation will come into effect by 2020. As per this, orthopedic accessories manufacturers need to maintain a unique device identity to improve device traceability, including aesthetic devices that have the same characteristics and risks profile as that of analogous medical devices. The regulation mandates the manufacturers to introduce an Implant card, which would contain information about the implanted medical device for a patient. MDR 2017/745 also aims at strengthening post-market surveillance requirements for manufacturers and setting high standards of quality and safety for medical devices for the health and safety of patients and users. Similarly, the management system standard for medical devices - ISO 13485 has been updated. In Conventus Orthopedics, a US-based commercial stage orthopedics company acquired Flower Orthopedics for an undisclosed amount. The acquisition would be an opportunity for Conventus to tackle ongoing concerns regarding viral and infection risks with heavy reusable orthopaedic implant trays. Flower Orthopedics is a US-based manufacturer of single use implant and instrument kits. North America was the largest region in the global orthopedic accessories market in 2022. Western Europe was the second-largest region in the orthopedic accessories market report. The regions covered in the orthopedic accessories industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic accessories market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The orthopedic accessories market consists of sales of products such as bone cement, casting system, and removal system. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic accessories market research report is one of a series of new reports from The Business Research Company that provides orthopedic accessories market statistics, including orthopedic accessories industry global market size, regional shares, competitors with a orthopedic accessories market share, detailed orthopedic accessories market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic accessories industry. The orthopedic accessories market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Joint reconstruction devices are implantable medical devices that are used to operate as replacements for the shoulder joint, hip joint or knee joint to restore the function of a joint. A joint can be restored by resurfacing the bones. The main product types of joint reconstruction devices and equipment are knee reconstruction devices, hip reconstruction devices, and extremity reconstruction devices. Hip reconstruction devices are medical devices intended to restore mobility and relieve pain associated with arthritis and other hip diseases or injuries. The various applications involved are arthrodesis, arthroscopy, joint replacement surgery, osteotomy, resurfacing surgery, and small joint surgery. The various end-users are hospitals, orthopedic clinics, and ambulatory surgical centres. The global joint reconstruction devices and equipment market is segmented - 1) By Product Type: Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices 2) By Application: Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery 3) By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers The global joint reconstruction devices and equipment market size will grow from $19.94 billion in 2022 to $21.28 billion in 2023 at a compound annual growth rate (CAGR) of 6.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the joint reconstruction devices and equipment is expected to grow from $26.13 billion in 2027 at a CAGR of 5.3%. The presence of a large pool of patients in joint reconstruction diseases is driving the market. Patients are preferring joint replacement treatment instead of other treatments for joint diseases, because of increased safety and reliability. The rise in joint reconstruction diseases such as osteoarthritis, knee and hip injury, road accident, cartilage, and labral injury is increasing the patient pool. For instance, osteoarthritis is a common disorder of joints that mainly affects the geriatric population across the globe. This condition can be treated by joint replacement surgeries using orthopedic knee and hip implants surgery According to the Arthritis Foundation, about 67 million people are expected to suffer from arthritis by 2030. This rise in the patient pool for joint diseases is driving the demand for the joint reconstruction devices and equipment market, significantly impacting the joint reconstruction devices and equipment market growth. Major players in the joint reconstruction devices and equipment market are Smith & Nephew, Stryker, Zimmer Biomet, B. Braun Melsungen, Wright Medical Group, DePuy Synthes, Johnson & Johnson, Aesculap Implant Systems Inc., and Arthrex Inc. The joint reconstruction devices and equipment market is being restrained due to the high rate of product recalls. The medical devices industry including joint reconstruction devices is seeing a significant spike in product recalls during recent years, due to defects, concerns regarding patient safety, software issues, mislabeling issues, quality issues, and others, thereby affecting the growth of the market. For example, DePuy had to recall several of its Attune knee replacement systems, due to safety concerns. Similarly. Similarly, Zimmer Biomet, a USA-based medical device company, recalled its 5 products related to the Oxford product line due to racking and separation issues. The product line recalled included the Oxford Partial Knee System Right and Left Medial Tibial Tray (of various sizes), and the Oxford Unicompartmental Knee Phase 3 Tibial Impactor. This high recall rate is affecting the sales of joint reconstruction devices and hampering the growth of the joint reconstruction devices and equipment market. Companies in joint reconstruction devices are increasingly investing in 3D printing technology due to its significant improvement over traditional joint reconstruction surgery. This technique uses for reconstructions of bones as a base before the surgery plan so the patient can get a preoperative MRI or CT scan. These features are particularly beneficial for patients in terms of safety concerns, which can affect adherence to treatment regimens. For instance, in August 2022, Exactech, a US-based developer of innovative implants and instrumentation launched their noval total hip arthroplasty system. Joint reconstruction devices and equipment are Class III devices that come under the orthopedic devices market and orthopedic devices manufacturing is monitored by regulatory bodies such as the US Food and Drug Administration (FDA). For instance, under the Federal Food, Drug, and Cosmetic Act (FFDCA), all medical device manufacturers must register their facilities and list their devices with US FDA, and follow general controls requirements. The manufacturers can gain premarket approval through 2 methods. The first method consists of conducting clinical studies and submitting a premarket approval (PMA) application which includes evidence providing reasonable assurance that the device is safe and effective. The other method involves submitting a 510(k)-notification demonstrating that the device is substantially equivalent to a device already on the market (a predicate device) that does not require a PMA. In January 2021, Stryker corporation, a US-based medical technologies company, acquired OrthoSensor for an undisclosed amount. The acquisition would help Stryker to continue its growth in the smart sensor technologies. OrthoSensor is a US-based developer of orthopaedic devices and digital knee replacement solutions. North America was the largest region in the global joint reconstruction devices and equipment market in 2022. Asia-Pacific was the second largest market in joint reconstruction devices and equipment market share. The regions covered in the global joint reconstruction devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the joint reconstruction devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The joint reconstruction devices and equipment market consist of sales of knee reconstruction devices, hip reconstruction devices, and extremity reconstruction devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The joint reconstruction devices and equipment market research report is one of a series of new reports from The Business Research Company that provides joint reconstruction devices and equipment market statistics, including joint reconstruction devices and equipment industry global market size, regional shares, competitors with a joint reconstruction devices and equipment market share, detailed joint reconstruction devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the joint reconstruction devices and equipment industry. This joint reconstruction devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global medical equipment is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the growth of the medical equipment market during the forecast period. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical equipment market data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market share. The regions covered in the medical equipment market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the medical equipment market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified medical equipment market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the medical equipment market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global medical equipment market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, medical equipment market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Orthopedic biomaterials are materials intended to be inserted into the human body as constituents of devices designed to perform certain biological functions by either substituting or repairing various tissues, such as bones, cartilage, ligaments, tendons, and others. The orthopedic biomaterials market covered in this report is segmented by material type into ceramics and bioactive glasses, calcium phosphate cement, polymers, metal, and composites. Polymers are used as orthopedic biomaterials intended to be inserted into the human body as constituents. The various applications are orthopedic implants, joint replacement/reconstruction, bio-resorbable tissue fixation, orthobiologics, and viscosupplementation. These are used by various end-users such as hospitals, clinics, and others. The global orthopedic biomaterials market is segmented - 1) By Material Type: Ceramics & Bioactive Glasses, Calcium Phosphate Cements, Polymers, Metal, Composites 2) By Application: Orthopedic Implants, Joint Replacement/Reconstruction, Bio-Resorbable Tissue Fixation, Orthobiologics, Viscosupplementation 3) By End-User: Hospitals, Clinics, Other End-Users The global orthopedic biomaterials market grew from $16.9 billion in 2022 to $18.62 billion in 2023 at a compound annual growth rate (CAGR) of 10.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic biomaterials is expected to grow from $29.69 billion in 2027 at a CAGR of 12.4%. The rise in the incidence of musculoskeletal disorders is expected to drive the orthopedic biomaterials market. According to the World Health Organization (WHO) report, musculoskeletal conditions are the leading contributor to disability worldwide. About 20-33% of the population suffer from a musculoskeletal disability. Musculoskeletal disorders induce fractures, swelling, and discomfort in the joints, ligaments, and tendons that cause movement disabilities. The burden of musculoskeletal conditions is known to increase with age. The sustainable development goals (SDGs) and the Decade of Healthy Ageing 2020–2030 have called for increased global attention and action on musculoskeletal health. Biomaterials are used to treat these disorders. Hence, the incidence of musculoskeletal disorders is projected to drive the orthopedic biomaterials market. Major players in the orthopedic biomaterials market are Zimmer Biomet Holdings Inc., Stryker Corporation, Victrex PLC (Invibio Ltd.), Globus Medical Inc., CAM Bioceramics B.V., Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Evonik Industries AG, and Koninklijke DSM N.V. (DSM Biomedical B.V.). The high cost of conducting clinical trials is expected to hinder the biomaterials market growth. The orthopedic biomaterials are directly implanted in the body. Therefore, it is important to prove the safety and biocompatibility of these materials. However, the high cost of conducting clinical trials is acting as a major roadblock. The clinical studies are expensive and time-consuming due to the number of tests required, and the length of each test. The investment of resources, time, and funding grows with successive stages. Additional costs are associated with the result of the trials at different phases. For instance, the cost of a failed phase 3 trial is not just the cost associated with the trial itself but the cost of all prior trials as well as the cost of lost time pursuing a potentially viable alternative or repeating the steps. Therefore, the high cost of conducting clinical trials is expected to impact the orthopedic biomaterials market. 3D printing of orthopedic implants is one of the recent developments in the orthopedic biomaterials market. 3D printing technology is used to produce a large range of medical equipment, such as those with complicated structures or characteristics to suit a patient’s particular anatomy. 3D printing of orthopedic implants enables the design of more natural anatomical shapes, as well as the design of porous bone replacement scaffolds that can be easily integrated into the design of the implant. This allows natural bone regeneration to generate higher reliability of the implant. 3D printing of orthopedic implants is a trend in the orthopedic biomaterial market that is attracting many players. For instance, Evonik, a Germany-based chemical company has invested in Meditool, a Chinese-based 3d printed implant start-up that produces models and implants by using polyether ketone (PEEK) polymer supplied by Evonik. In November 2020, Olympus, a Japanese medical technology company, acquired FH Ortho for an undisclosed amount. The acquisition would help Olympus to grow in the field of orthopaedic minimally invasive surgery. FH Ortho is a France based orthopaedics company. North America was the largest region in the orthopedic biomaterials market in 2022. Western Europe was the second largest region in the orthopedic biomaterials market report. The regions covered in the orthopedic biomaterials analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic biomaterials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The orthopedic biomaterials market consists of sales of glass-ceramic and bioactive glasses and calcium phosphate cements. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic biomaterials market research report is one of a series of new reports from The Business Research Company that provides orthopedic biomaterials market statistics, including orthopedic biomaterials industry global market size, regional shares, competitors with a orthopedic biomaterials market share, detailed orthopedic biomaterials market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic biomaterials industry. The orthopedic biomaterials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Orthopedic power tools refer to tools used to perform surgery on bone or bone fragments. These tools perform functions like drilling, sawing, reaming, screwing, and others. Orthopedic power tools are employed in every area of orthopedic surgery, from wound treatment by pulse lavage to drilling and reaming in long bone fractures with screws and intramedullary nails. The main products of orthopedic power tools are large bone orthopedic power tools, small bone orthopedic power tools, high speed bone orthopedic power tools, and orthopedic reamers. Large bone orthopedic power tools are developed for treatments like hip and complete knee replacements, reaming, intramedullary nailing, drilling, and driving screws in large bones. These tools allow orthopedician to conveniently handle complex surgeries. These tools are used on various power sources which include pneumatic powered, battery operated, and electric powered. The orthopetic power tools are mostly used by orthopedic hospitals, orthopedic clinics and ambulatory surgical centers for treating various orthopedic related ailments. The global orthopedic power tools market is segmented - 1) By Product Type: Large Bone Orthopedic Power Tools, Small Bone Orthopedic Power Tools, High Speed Bone Orthopedic Power Tools, Orthopedic Reamers 2) By Technology: Pneumatic Powered, Battery Operated, Electric Powered 3) By End User: Orthopedic Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers The global orthopedic power tools market size grew from $1.07 billion in 2022 to $1.13 billion in 2023 at a compound annual growth rate (CAGR) of 5.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size report orthopedic power tools market is expected to grow to $1.38 billion in 2027 at a CAGR of 5.2%. The increasing prevalence of orthopedic disorders among the global population is expected to boost the orthopedic power tools market. The focus of orthopedics is the treatment of abnormalities or functional limitations of the skeletal system, notably the spine and its accompanying structure, ligaments, and muscles. The orthopedic power tools are used for treating these orthopedic ailments. For example, according to the WHO, approximately 1.71 billion people had musculoskeletal conditions worldwide in 2021. Hence the demand for orthopedic power tools is expected to increase in the forecast period as there is an increase in orthopedic disorders. Major players in the orthopedic power tools market are De Soutter Medical, B Braun Melsungen AG, Aygun Surgical Instruments Co Inc., Medtronic plc, DePuy Synthes Companies, Zimmer Biomet, Stryker Corporation, Exactech Inc., Nouvag AG, Medical Bees GmbH, IMedicom Co Ltd., Adeor Medical AG, Shanghai Bojin Medical Instrument, Allotech Co Ltd., Adeor, ceterixorthopeddics, Orthopromed and MatOrtho. Adoption of advanced and innovative technology is a key trend in the orthopedic power tools market. Innovation for sterilizing the orthopedic power tools is taking place to improve the efficiency of the treatment procedure. For Instance, in May 2021, Arbutus Medical launched SteriTrak, a new kit to help trauma centers execute bone traction more efficiently and quickly while ensuring cleanliness. The kit allows the emergency departments to quickly acquire sterile bone traction equipment when time is limited. SteriTrak helps apply temporary traction under a minute in case of terrible bone fractures. In December 2020, Zimmer Biomet, a US-based medical device company, acquired A&E Medical Corp in an all cash deal valued to be about $250 million. As a part of the acquisition, Zimmer Biomet will have access to the complete portfolio of A&E Medical which includes sternal closure devices—including sternal sutures, cable systems, and rigid fixation—along with a range of single-use complementary temporary pacing wire and surgical punch products. With the addition of this protfolio, Zimmer Biomet will attain the capabilities to offer a comprehensive suite of sternal closure products, including rigid fixation and address a variety of unmet patient and surgical needs. North America was the largest region in the orthopedic power tools market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic power tools market share report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the orthopedic power tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA. The orthopedic power tools market consists of sales of battery, pneumatic, and electric. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic power tools market research report is one of a series of new reports from The Business Research Company that provides orthopedic power tools market statistics, including orthopedic power tools industry global market size, regional shares, competitors with an orthopedic power tools market share, detailed orthopedic power tools market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic power tools industry. This orthopedic power tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Orthopedic regenerative surgical products are used for the treatment of joint pains, gout, articular defects, fibromyalgia, and osteoarthritis, as well as trauma and joint replacement, joint problems, regenerative orthopedic medicine using platelet-rich plasma (PRP) which is frequently the nonsurgical treatment of choice to assist patients in healing and repairing many musculoskeletal (orthopedic) injuries such as joint, tendon, ligament, and muscular injuries. The orthopedic regenerative surgical products are curing many other musculoskeletal injuries. The main type of orthopedic regenerative surgical products is allograft, synthetic, cell-based, and viscosupplements. Allograft is a tissue transplant between genetically distinct individuals of the same species. An allograft is not the same as an autograft, which uses tissue from the same person's body and is thus genetically identical. Anterior tibialis tendon, frozen femoral head, freeze-dried bone chips, DBM putty, acellular dermis, and amniotic membrane are examples of human allografts. These are used by hospitals, ambulatory surgical centers, and others, in the treatment of orthopedic pain management, trauma repair, cartilage and tendon repair, and joint reconstruction. The global orthopedic regenerative surgical products market is segmented - 1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements 2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction 3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users The global orthopedic regenerative surgical products market size grew from $3.89 billion in 2022 to $4.2 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The orthopedic regenerative surgical products market size is expected to grow to $5.38 billion in 2027 at a CAGR of 6.4%. The rising prevalence of orthopedic diseases across the globe is likely to contribute to the growth of the orthopedic regenerative surgical products market. The orthopedic regenerative surgical products contribute to the prevention of orthopedic problems such as fractures, sprains, and strains, as well as lifelong conditions associated with ongoing functional limitations and disability. Approximately 1.71 billion people have musculoskeletal conditions worldwide. The orthopedic disease musculoskeletal conditions are the leading contributor to disability worldwide, with low back pain being the single leading cause of disability in 160 countries. Hence, the rising prevalence of orthopedic diseases drives the market for orthopedic regenerative surgical products. Major players in the orthopedic regenerative surgical products market are Baxter, Zimmer Biomet, Stryker, Smith&Nephew, Allosource, Amniox Medical Inc., Anika Therapeutics Inc., Vericel Corporation, Vsy Biotechnology GmbH, Aptissen S.A., Mimedx, and TissueTech Inc. Technological advancements are a key trend gaining popularity in the orthopedic regenerative surgical products market. For instance, in 2021, the USA-based Anika Therapeutics, Inc., a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its proprietary hyaluronic acid ("HA") technology, announced the successful completion of the first human surgical procedure with its injectable HA-based bone repair therapy for the treatment of bone voids and other skeletal system bone defects caused by trauma or age-related degeneration. Around 900,000 people require treatment for bone voids and other bone defects of the knee, which cause pain and impaired function and may necessitate total joint replacement therapy. In 2021, Stryker, a US-based multinational medical technologies corporation, acquired OrthoSensor Inc for an undisclosed amount. This acquisition aimed to develop the medical & surgical, neurotechnology and spine that help improve patient and hospital outcomes. OrthoSensor Inc is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor's headquarters is in Dania Beach, USA. North America was the largest region in the orthopedic regenerative surgical products market in 2022 and is also expected to be the fastest-growing region in the forecast period. The regions covered in orthopedic regenerative surgical products market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic regenerative surgical products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The orthopedic regenerative surgical products market consists of sales of allograft wedges, allowrap DS, BIO4, DBM, hydroset, imbibe, nerve repair, and prochondrix CR.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic regenerative surgical products market research report is one of a series of new reports from The Business Research Company that provides orthopedic regenerative surgical products market statistics, including orthopedic regenerative surgical products industry global market size, regional shares, competitors with a orthopedic regenerative surgical products market share, detailed orthopedic regenerative surgical products market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic regenerative surgical products industry. This orthopedic regenerative surgical products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Orthopedic devices are used to stabilize the body posture by correcting deformities, restoring the function of the human skeletal system, articulations, and associated structures either by replacing or reinforcing the damaged part. The main types in the orthopedic devices market are joint reconstruction devices and equipment; spinal surgery devices and equipment, trauma fixation devices and equipment, orthobiologics devices and equipment, arthroscopy devices and equipment, orthopedic braces and support devices and equipment, and craniomaxillofacial (CMF) devices and equipment, orthopedic prosthetics. Spinal surgery devices are the devices used during spine surgery to stabilize the spine to prevent motion while fusion occurs between two or more vertebrae. The type of expenditure is public, private. The products used are instruments/equipment, disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The global orthopedic devices market is segmented - 1) By Type: Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global orthopedic devices market size grew from $43 billion in 2022 to $45.79 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global orthopedic devices is expected to grow to $55.75 billion in 2027 at a CAGR of 5.0%. The increase in the patient pool due to the rising geriatric population globally contributed significantly to the growth of the orthopedic devices market during the historic period. According to the World Health Organization, the number of people aged 60 years and above was 1 billion in 2020 and the number will rise to 1.4 billion by 2030 and it will reach 2.1 billion by 2050. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. These factors increased the demand for these products and drove the growth of the orthopedic devices market during the historic period. Major companies in the orthopedic devices market include Johnson & Johnson, Zimmer Biomet Holdings, STRYKER CORPORATION, Medtronic Inc., Smith & Nephew plc, Colfax Corporation, NuVasive, Inc., Wright Medical Group, Inc., Globus Medical Inc., and B. Braun Group. The orthopedic devices market was limited by the development of new drugs and therapies which allow patients to avoid surgical procedures. With advances in tissue engineering, stem-cell therapy, and other treatment alternatives such as platelet-rich plasma (PRP) injections, patients can avoid surgical procedures for medical conditions such as arthritis, tendonitis, and others. This has negatively impacted the demand for orthopedic devices as an increasing number of people opted for these alternative treatment methods, to avoid risks and complications associated with orthopedic procedures. Biodegradable implants are increasingly being used in trauma orthopedic surgeries. Biodegradable implants are used to replace a missing biological structure, support a damaged biological structure, and enhance the existing bone structure. Biodegradable products such as reabosorbable polymers composed of polyglycolic acid and polylactic acid manufactured in the form of plates, screws, and pins are replacing traditional devices like plates and screws, which are more expensive. Surgeons are preferring biodegradable implants to replace conventional implants, as biodegradable implants can be engineered to provide temporary support for bone fractures; can degrade at a rate matching new tissue formation; can eliminate the need for the second surgery, and are highly useful in fracture fixation in children; and result in less implant-related infections. For instance, Stryker Corporation offers orthrobiologics such as bone repair biodegradable products that are used in bone regeneration and bone healing, soft tissue regeneration, and muscle connection to bone. North America was the largest region in the global orthopedic devices market in 2022. Western Europewas the second largest region in the global orthopedic devices market share. The regions covered in the orthopedic devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the orthopedic devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The orthopedic devices market consists of sales of osteotomes, bone-cutting forceps, Gigli saws, and plate benders that are used for orthopedic surgeries and treatment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The orthopedic devices market research report is one of a series of new reports from The Business Research Company that provides orthopedic devices market statistics, including orthopedic devices industry global market size, regional shares, competitors with a orthopedic devices market share, detailed orthopedic devices market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic devices industry. This orthopedic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.